ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 117 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $320 | -100.0% | 8,984 | -61.1% | 0.02% | -87.1% |
| Q2 2021 | $1,912,000 | -2.7% | 23,086 | -9.9% | 0.19% | -12.3% |
| Q4 2020 | $1,966,000 | +614.9% | 25,626 | +162.7% | 0.21% | +909.5% |
| Q3 2019 | $275,000 | +39.6% | 9,756 | -9.1% | 0.02% | +90.9% |
| Q1 2019 | $197,000 | +60.2% | 10,735 | -37.3% | 0.01% | +57.1% |
| Q1 2018 | $123,000 | +57.7% | 17,116 | -5.0% | 0.01% | +75.0% |
| Q3 2017 | $78,000 | – | 18,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
| Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
| Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
| COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
| Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
| JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
| WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
| M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
| Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
| Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |